CFN
JAZZ icon

Cordasco Financial Network’s Jazz Pharmaceuticals JAZZ Stock Holding History

Cordasco Financial Network’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-50
Closed -$6K – 534
2020
Q2 		$6K Hold
50
– – 0.01% 340
2020
Q1 		$5K Buy
+50
New +$6.46K 0.01% 327
2018
Q3 		– Sell
-14
Closed -$2K – 376
2018
Q2 		$2K Buy
+14
New +$2.29K ﹤0.01% 357

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Cordasco Financial Network's JAZZ Position: Q3 2020 in Review

Cordasco Financial Network sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2020, closing a stake of 50 shares — an estimated $6K sold.

Cordasco Financial Network first reported a position in JAZZ in Q2 2018 and held it in 3 quarters. The position peaked at $6K in Q2 2020. 389 funds tracked by Wall St. Rank hold JAZZ as of Q3 2020.

  • Cordasco Financial Network reported no remaining Jazz Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Cordasco Financial Network sold 50 Jazz Pharmaceuticals shares in Q3 2020, an estimated $6K.
  • Cordasco Financial Network first reported a position in Jazz Pharmaceuticals in Q2 2018 and held it in 3 quarters.
  • Cordasco Financial Network's Jazz Pharmaceuticals position peaked at $6K in Q2 2020.
  • 389 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2020.

Based on Cordasco Financial Network's 13F filing for Q3 2020, filed 13 Oct 2020.